Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

2.4%

1 terminated/withdrawn out of 42 trials

Success Rate

95.7%

+9.2% vs industry average

Late-Stage Pipeline

31%

13 trials in Phase 3/4

Results Transparency

27%

6 of 22 completed trials have results

Key Signals

7 recruiting6 with results

Enrollment Performance

Analytics

N/A

15(44.1%)

Phase 4

9(26.5%)

Phase 2

6(17.6%)

Phase 3

4(11.8%)

34Total

N/A(15)

Phase 4(9)

Phase 2(6)

Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (42)

Showing 20 of 42 trials

NCT07198581Not ApplicableRecruiting

AI-Assisted Chemotherapy Side Effect Management

Role: lead

NCT07413120Phase 3Completed

Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery

Role: lead

NCT04014803Phase 4Recruiting

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Role: collaborator

NCT07268820Phase 4Recruiting

Heartburn, Gastroesophageal Reflux Disease

Role: lead

NCT06505577Recruiting

Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study

Role: lead

NCT05770687Recruiting

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study

Role: collaborator

NCT02619994Phase 2Completed

Treatment Shortening of MDR-TB Using Existing and New Drugs

Role: collaborator

NCT06522113Phase 4Completed

Cilostazol and Aspirin in Stroke and TIA

Role: lead

NCT04938076Not ApplicableCompleted

Efficacy of Transcranial Direct Current Stimulation in Acute Ischemic Stroke

Role: lead

NCT04147065Phase 4Recruiting

Helicobacter Pylori Eradication According to DPO-PCR Methods (K-CREATE) Study)

Role: lead

NCT04462133Not ApplicableWithdrawn

Optimal Tailored Treatment for H. Pylori Infection

Role: lead

NCT02715518Not ApplicableCompleted

FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease

Role: collaborator

NCT05381194Phase 4Recruiting

BPaL(M) Regimen for the Treatment of MDR/RR-TB

Role: collaborator

NCT04328987Completed

Safety of Cold Snare Polypectomy in Patients With Uninterrupted Antiplatelet Agent

Role: lead

NCT01239914Completed

CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)

Role: collaborator

NCT04503291Not ApplicableUnknown

Comparison Between Transpapillary and Suprapapillary Metal Stent

Role: collaborator

NCT04674774Not ApplicableUnknown

Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection

Role: lead

NCT03243851Phase 2Completed

Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma

Role: collaborator

NCT04547231Unknown

Impact of Coronary CT Angiography, Physiologic Assessment and Pharmacotherapy on the Clinical Outcomes

Role: collaborator

NCT02799368Phase 3Completed

Balanced Salt Solution Versus 0.9% Saline Infusion for Prevention of Contrast-induced Acute Kidney Injury (BASIC Trial)

Role: collaborator